Form 4: Allovir CEO Diana Brainard Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Allovir's CEO, Diana Brainard, sold shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- On August 20, 2024, Diana Brainard, CEO of Allovir, Inc., sold 5,390 shares of common stock.
- The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
- The shares were sold at a weighted average price of $0.7413, with individual transactions ranging from $0.7384 to $0.745.
- Following the transaction, Brainard directly owns 753,923 shares of Allovir common stock.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction (selling shares to cover taxes), so the sentiment is neutral.
Industry Context
Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, allowing investors to track executive sentiment and potential alignment with company performance.
Stakeholder Impact
- The sale of shares by the CEO could have a minor impact on shareholder sentiment, although it is a common practice for covering tax obligations.
Key Dates
| Date | Description |
|---|---|
| 08/20/2024 | Date of stock sale transaction |
| 08/22/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.